BC

Birchview Capital Portfolio holdings

AUM $101M
This Quarter Return
+18.58%
1 Year Return
+34.62%
3 Year Return
+103.2%
5 Year Return
+107.72%
10 Year Return
+352.1%
AUM
$115M
AUM Growth
+$115M
Cap. Flow
-$6.39M
Cap. Flow %
-5.53%
Top 10 Hldgs %
66.83%
Holding
65
New
5
Increased
9
Reduced
7
Closed
4

Top Buys

1
ACAD icon
Acadia Pharmaceuticals
ACAD
$2.31M
2
EQT icon
EQT Corp
EQT
$1.27M
3
CSTL icon
Castle Biosciences
CSTL
$684K
4
ATEC icon
Alphatec Holdings
ATEC
$612K
5
KALV icon
KalVista Pharmaceuticals
KALV
$417K

Top Sells

1
SILK
Silk Road Medical, Inc. Common Stock
SILK
$4.27M
2
HROW icon
Harrow
HROW
$3.47M
3
ETRN
Equitrans Midstream Corporation Common Stock
ETRN
$1.73M
4
NBIX icon
Neurocrine Biosciences
NBIX
$1.38M
5
ELUT icon
Elutia
ELUT
$878K

Sector Composition

1 Healthcare 97.17%
2 Energy 2.83%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
TXG icon
26
10x Genomics
TXG
$1.74B
$677K 0.59%
30,000
– –
HALO icon
27
Halozyme
HALO
$8.56B
$572K 0.5%
10,000
– –
AXDX
28
DELISTED
Accelerate Diagnostics
AXDX
$556K 0.48%
325,239
– –
CYTK icon
29
Cytokinetics
CYTK
$4.23B
$528K 0.46%
10,000
– –
INBX icon
30
Inhibrx
INBX
$408M
$503K 0.44%
32,110
+20,000
+165% +$313K
KROS icon
31
Keros Therapeutics
KROS
$618M
$406K 0.35%
7,000
– –
APLS icon
32
Apellis Pharmaceuticals
APLS
$3.48B
$404K 0.35%
14,000
– –
TMCI icon
33
Treace Medical Concepts
TMCI
$464M
$396K 0.34%
+68,350
New +$396K
XENE icon
34
Xenon Pharmaceuticals
XENE
$2.98B
$394K 0.34%
10,000
– –
KPTI icon
35
Karyopharm Therapeutics
KPTI
$61.7M
$390K 0.34%
469,832
– –
CHRS icon
36
Coherus Oncology, Inc. Common Stock
CHRS
$135M
$387K 0.34%
372,000
+102,000
+38% +$106K
ARVN icon
37
Arvinas
ARVN
$568M
$369K 0.32%
15,000
– –
PGNY icon
38
Progyny
PGNY
$2.04B
$369K 0.32%
22,000
– –
BHVN
39
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$368K 0.32%
7,365
– –
AXSM icon
40
Axsome Therapeutics
AXSM
$6.05B
$359K 0.31%
4,000
– –
CGEM icon
41
Cullinan Oncology
CGEM
$445M
$335K 0.29%
20,000
– –
WVE icon
42
Wave Life Sciences
WVE
$1.53B
$328K 0.28%
40,000
– –
SWTX
43
DELISTED
SpringWorks Therapeutics
SWTX
$320K 0.28%
10,000
– –
NVCR icon
44
NovoCure
NVCR
$1.38B
$313K 0.27%
20,000
– –
SRPT icon
45
Sarepta Therapeutics
SRPT
$1.78B
$312K 0.27%
2,500
– –
BCRX icon
46
BioCryst Pharmaceuticals
BCRX
$1.74B
$304K 0.26%
40,000
– –
FOLD icon
47
Amicus Therapeutics
FOLD
$2.34B
$299K 0.26%
28,000
– –
BPMC
48
DELISTED
Blueprint Medicines
BPMC
$250K 0.22%
+2,700
New +$250K
XNCR icon
49
Xencor
XNCR
$580M
$247K 0.21%
12,300
– –
GOSS icon
50
Gossamer Bio
GOSS
$562M
$136K 0.12%
138,176
– –
1
2
3